Avoid drinking large volumes during meals, as this fills your stomach and worsens early satiety and nausea
1 About the Trial Trial Name: Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese Phase : 2 Study Type: Interventional ClinicalTrials.gov ID: NCT05616013 Trial Sponsor: Eli Lilly and Company Completion Date: June 14, 2025 ClinicalTrials.gov/study/NCT05616013 Body Composition Changes Total body fat mass reduction at week 72 was 45.7% with high-dose combination therapy, 27.8% with semaglutide 2.4 mg, and 28.5% with bimagrumab 30 mg/kg
If the combination persists beyond 2 to 3 weeks or becomes severe enough to cause dehydration, this warrants a conversation with your healthcare provider
Some studies suggest it could help with: Lowering blood pressure Improving insulin sensitivity Enhancing overall cardiovascular function If youre looking to support longevity and overall wellness, BPC-157 is a powerful tool for optimizing heart and metabolic health
This psychological aspect is essential to consider, especially if semaglutide has been a crucial part of your health journey